Mattias Belting

Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial

Ehinger, Erik; Darabi, Anna; Visse, Edward; Edvardsson, Charlotte et al.

Part of Trials, 2025

• DOI for Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial
• Download full text (pdf) of Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial

Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

Wicher, Grzegorz; Roy, Ananya; Vaccaro, Alessandra; Vemuri, Kalyani et al.

Part of Neuro-Oncology Advances, 2025

• DOI for Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
• Download full text (pdf) of Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

Godina, Christopher; Khazaei, Somayeh; Belting, Mattias; Vallon-Christersson, Johan et al.

Part of PLOS ONE, 2024

• DOI for High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
• Download full text (pdf) of High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

Godina, Christopher; Belting, Mattias; Vallon-Christersson, Johan; Isaksson, Karolin et al.

Part of Scientific Reports, 2024

• DOI for Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
• Download full text (pdf) of Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

Analysis of Extracellular Vesicle-Associated Proteoglycans

Poças, Juliana; Belting, Mattias

Part of Methods in Molecular Biology, p. 125-139, 2023

• DOI for Analysis of Extracellular Vesicle-Associated Proteoglycans

Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial

Ehinger, Erik; Darabi, Anna; Visse, Edward; Edvardsson, Charlotte et al.

Part of Trials, 2025

• DOI for Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial
• Download full text (pdf) of Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial

Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

Wicher, Grzegorz; Roy, Ananya; Vaccaro, Alessandra; Vemuri, Kalyani et al.

Part of Neuro-Oncology Advances, 2025

• DOI for Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
• Download full text (pdf) of Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

Godina, Christopher; Khazaei, Somayeh; Belting, Mattias; Vallon-Christersson, Johan et al.

Part of PLOS ONE, 2024

• DOI for High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
• Download full text (pdf) of High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

Godina, Christopher; Belting, Mattias; Vallon-Christersson, Johan; Isaksson, Karolin et al.

Part of Scientific Reports, 2024

• DOI for Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
• Download full text (pdf) of Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

Analysis of Extracellular Vesicle-Associated Proteoglycans

Poças, Juliana; Belting, Mattias

Part of Methods in Molecular Biology, p. 125-139, 2023

• DOI for Analysis of Extracellular Vesicle-Associated Proteoglycans

Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer

Godina, Christopher; Tryggvadottir, Helga; Bosch, Ana; Borgquist, Signe et al.

Part of Breast Cancer Research and Treatment, p. 335-347, 2023

• DOI for Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
• Download full text (pdf) of Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer

Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival

Pocas, Juliana; Marques, Catarina; Gomes, Catarina; Otake, Andreia Hanada et al.

Part of Proceedings of the National Academy of Sciences of the United States of America, 2023

• DOI for Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival
• Download full text (pdf) of Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival

Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN-A Randomized Trial with Low Molecular Weight Heparin

Bendahl, Par-Ola; Belting, Mattias; Gezelius, Emelie

Part of Cancers, 2023

• DOI for Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN-A Randomized Trial with Low Molecular Weight Heparin
• Download full text (pdf) of Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN-A Randomized Trial with Low Molecular Weight Heparin

Endogenous incretin levels and risk of first incident cancer: a prospective cohort study

Jujic, Amra; Godina, Christopher; Belting, Mattias; Melander, Olle et al.

Part of Scientific Reports, 2023

• DOI for Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
• Download full text (pdf) of Endogenous incretin levels and risk of first incident cancer: a prospective cohort study

Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma

Ehinger, Erik; Kopecky, Jan; Darabi, Anna; Visse, Edward et al.

Part of BMC Neurology, 2023

• DOI for Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma
• Download full text (pdf) of Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma

Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization

Governa, Valeria; Talbot, Hugo; de Oliveira, Kelin Goncalves; Cerezo-Magana, Myriam et al.

Part of Proceedings of the National Academy of Sciences of the United States of America, 2022

• DOI for Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization

Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)

Gezelius, Emelie; Bendahl, Paer-Ola; Gallo, Widet; de Oliveira, Kelin Goncalves et al.

Part of Cancers, 2022

• DOI for Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
• Download full text (pdf) of Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer

Godina, Christopher; Chandran, Vineesh Indira; Barbachowska, Magdalena; Tryggvadottir, Helga et al.

Part of Translational Oncology, 2022

• DOI for Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
• Download full text (pdf) of Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer

Glioblastoma CD105(+) cells define a SOX2(-) cancer stem cell-like subpopulation in the pre-invasive niche

Li, Jiaxin; Ek, Fredrik; Olsson, Roger; Belting, Mattias et al.

Part of Acta neuropathologica communications, 2022

• DOI for Glioblastoma CD105(+) cells define a SOX2(-) cancer stem cell-like subpopulation in the pre-invasive niche
• Download full text (pdf) of Glioblastoma CD105(+) cells define a SOX2(-) cancer stem cell-like subpopulation in the pre-invasive niche

Hypoxic Induction of Exosome Uptake through Proteoglycan-Dependent Endocytosis Fuels the Lipid Droplet Phenotype in Glioma

Cerezo-Magana, Myriam; Christianson, Helena C.; van Kuppevelt, Toin H.; Forsberg Nilsson, Karin et al.

Part of Molecular Cancer Research, p. 528-540, 2021

• DOI for Hypoxic Induction of Exosome Uptake through Proteoglycan-Dependent Endocytosis Fuels the Lipid Droplet Phenotype in Glioma

The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2

Berg, Tracy J.; Marques, Carolina; Pantazopoulou, Vasiliki; Johansson, Elinn et al.

Part of Cancer Research, p. 2101-2115, 2021

• DOI for The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2

The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial

Feldt, Maria; Menard, Julien; Rosendahl, Ann H.; Lettiero, Barbara et al.

Part of Cancer & Metabolism, 2020

• DOI for The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial
• Download full text (pdf) of The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial

Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1

Chandran, Vineesh Indira; Mansson, Ann-Sofie; Barbachowska, Magdalena; Cerezo-Magana, Myriam et al.

Part of Molecular Cancer Research, p. 644-656, 2020

• DOI for Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1

Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics

Chandran, Vineesh Indira; Welinder, Charlotte; de Oliveira, Kelin Goncalves; Cerezo-Magana, Myriam et al.

Part of Journal of Neuro-Oncology, p. 477-488, 2019

• DOI for Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics
• Download full text (pdf) of Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics

Biomarkers of venous thromboembolism in cancer: a silent echo from local events?

Gezelius, Emelie; Belting, Mattias

Part of Biomarkers in Medicine, p. 507-509, 2019

• DOI for Biomarkers of venous thromboembolism in cancer: a silent echo from local events?

Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)

Gezelius, E.; Bendahl, P. O.; de Oliveira, K. Goncalves; Ek, L. et al.

Part of European Journal of Cancer, p. 82-90, 2019

• DOI for Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
• Download full text (pdf) of Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)

Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma

Chandran, Vineesh Indira; Welinder, Charlotte; Mansson, Ann-Sofie; Offer, Svenja et al.

Part of Clinical Cancer Research, p. 3115-3127, 2019

• DOI for Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma

Proteoglycans: a common portal for SARS-CoV-2 and extracellular vesicle uptake

Cerezo-Magana, Myriam; Bång-Rudenstam, Anna; Belting, Mattias

Part of American Journal of Physiology - Cell Physiology, 2023

• DOI for Proteoglycans: a common portal for SARS-CoV-2 and extracellular vesicle uptake

Predictive biomarkers in radioresistant rectal cancer: A systematic review

Slipsager, Anna; Henrichsen, Sofie N.; Falkmer, Ursula G.; Dybkaer, Karen et al.

Part of Critical reviews in oncology/hematology, 2023

• DOI for Predictive biomarkers in radioresistant rectal cancer: A systematic review
• Download full text (pdf) of Predictive biomarkers in radioresistant rectal cancer: A systematic review

The pleiotropic role of proteoglycans in extracellular vesicle mediated communication in the tumor microenvironment

Cerezo-Magana, M.; Bang-Rudenstam, A.; Belting, Mattias

Part of Seminars in Cancer Biology, p. 99-107, 2020

• DOI for The pleiotropic role of proteoglycans in extracellular vesicle mediated communication in the tumor microenvironment
• Download full text (pdf) of The pleiotropic role of proteoglycans in extracellular vesicle mediated communication in the tumor microenvironment